We are live on
!
Find out more
MM
MWG Management Portfolio holdings
AUM
$81.3M
1-Year Est. Return
2.28%
This Fund
S&P 500
This Quarter
Est. Return
+19.13%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$812M
(+395%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
145.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RELX
RELX
|
+$1.16B |
| 2 |
Lyell Immunopharma
LYEL
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vir Biotechnology
VIR
|
+$11.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.66% |
| 2 | Industrials | 37.34% |
Similar funds
BCCM
BPC
AE
BHMP
LMKC
ASM
KDIA
CM
MWG Management's Q2 2021 Portfolio in Review
As of Q2 2021, MWG Management held 4 positions worth $1.02B, up 395% from $206M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MWG Management deployed $1.48B of net new capital in Q2 2021, opening 2 new positions. Its largest new stake was RELX: 43,539,020 shares worth $380M.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 100% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Vir Biotechnology, an estimated $11.4M trimmed.
- MWG Management's largest Q2 2021 buy was RELX: 43,539,020 shares worth $380M.
- MWG Management's biggest Q2 2021 reduction was Vir Biotechnology, cutting an estimated $11.4M.
- MWG Management's ten largest holdings make up 100% of its $1.02B portfolio in Q2 2021.
- MWG Management opened 2 new positions and closed 0 in Q2 2021.
- MWG Management's portfolio value rose 395% quarter-over-quarter to $1.02B.
Based on MWG Management's 13F filing for Q2 2021, filed 16 Aug 2021.